TFF Pharmaceuticals Inc (TFFP)
2.20
+0.04
(+1.85%)
USD |
NASDAQ |
May 17, 16:00
2.20
0.00 (0.00%)
Pre-Market: 20:00
TFF Pharmaceuticals Total Liabilities (Quarterly): 2.460M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.460M |
| September 30, 2023 | 1.194M |
| June 30, 2023 | 1.287M |
| March 31, 2023 | 1.668M |
| December 31, 2022 | 1.241M |
| September 30, 2022 | 2.205M |
| June 30, 2022 | 3.974M |
| March 31, 2022 | 2.197M |
| December 31, 2021 | 1.961M |
| September 30, 2021 | 1.558M |
| Date | Value |
|---|---|
| June 30, 2021 | 1.534M |
| March 31, 2021 | 1.817M |
| December 31, 2020 | 1.322M |
| September 30, 2020 | 1.573M |
| June 30, 2020 | 0.6898M |
| March 31, 2020 | 1.205M |
| December 31, 2019 | 1.543M |
| September 30, 2019 | 2.188M |
| June 30, 2019 | 1.624M |
| December 31, 2018 | 1.157M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.6898M
Minimum
Jun 2020
3.974M
Maximum
Jun 2022
1.750M
Average
1.573M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| Lifecore Biomedical Inc | 256.99M |
| Jaguar Health Inc | 43.57M |
| Genprex Inc | 3.254M |
| Aquestive Therapeutics Inc | 165.82M |
| NovaBay Pharmaceuticals Inc | 5.197M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.03M |
| Shareholders Equity (Quarterly) | 9.567M |